Sunday, December 05, 2021

DOH approves Covid booster shots this year for health workers, seniors

(SunStar Bacolod / CLMMRH-Horizon photo)

DEPARTMENT of Health (DOH) Secretary Francisco Duque III has approved the recommendation of the Health Technology Assessment Council (HTAC) on the provision of coronavirus disease (Covid-19) vaccine booster shots.

The HTAC recommended the booster vaccination of health workers and senior citizens in the fourth quarter of 2021, and among eligible priority groups, such as frontline essential workers and persons with comorbidities, in 2022.

It stressed, however, that this will be done once there is sufficient supply of vaccines and the acceptable vaccination coverage has already been achieved, especially the 70 percent of the target population in the hotspot regions including National Capital Region, Cebu, Davao, Iloilo, Calabarzon and Central Luzon.

Outside of these hotspot areas, the boosters will be given by 2022 to other eligible priority groups, provided that more than 50 percent of the target population for vaccination has been fully vaccinated in these localities or regions, Visayas Vaccination Operations Center (VVOC) spokesperson Dr. Mary Jean Loreche said Monday, Oct. 25, 2021.

“The rationale for the set threshold prior to implementation of booster includes ensuring maximum coverage for the primary series as the premature roll-out of booster vaccination without attaining acceptable coverage would exacerbate existing inequities. Considering the current vaccination rate and coverage, these set thresholds are deemed attainable and thus will not delay the booster program,” the HTAC said.

It said health workers and the elderly can be given booster shots six months after they completed the single- or two-dose Covid-19 vaccines.

Those who received two doses of Pfizer vaccines and a single dose of Janssen are allowed to be given only the same brand as boosters.

AstraZeneca recipients, though, may have Pfizer or the same brand as boosters.

Those who complete Sinovac’s Coronavac vaccine may receive Pfizer, AstraZeneca or the same brand as booster doses, while Moderna may be mixed and matched with Pfizer aside from the same brand.

Immunocompromised patients should be given additional doses of the same brand at least 28 days after they completed their vaccination.

HTAC suggested, however, that those who received Janssen and Sinovac be given Pfizer vaccines as an additional dose.

According to the World Health Organization (WHO), booster shots are being given to those whose immunity from the virus was decreasing over the time they completed the vaccine shots, while additional vaccine shots were for those who did not reach the ideal immune response level against the virus.

Those who commonly needed additional shots are individuals who are immunocompromised and the elderly.

The DOH, however, is yet to issue guidelines on the matter.

Loreche said immunocompromised individuals can get their booster shot in 2021 or 2022.

The country’s vaccine stockpile as of Sunday, October 24, 2021, was at 97,678,340.

National Task Force chief implementer and vaccine czar Carlito Galvez Jr. said on the sidelines of the arrival of Sinovac vaccines on Sunday, October 24, that they are expecting to achieve 100 million vaccine doses on stockpile before the end of October.

A total of 76,753,690 vaccine doses have been deployed across the Philippines of which 55,506,176 have already been administered.

A total of 25,614,366 individuals have completed their vaccination while 29,891,810 received the first dose. (SunStar Philippines, JOB)


SunStar website welcomes friendly debate, but comments posted on this site do not necessarily reflect the views of the SunStar management and its affiliates. SunStar reserves the right to delete, reproduce or modify comments posted here without notice. Posts that are inappropriate will automatically be deleted.

Forum rules:

Do not use obscenity. Some words have been banned. Stick to the topic. Do not veer away from the discussion. Be coherent. Do not shout or use CAPITAL LETTERS!

Create your own user feedback survey